Stress, Depression and Anxiety Disorders

Psychosomatic Medication Conference focusses on Functional somatic syndromes with a depression and the anxiety are of moderate magnitude but were highly significant statistically as when compared with a healthy persons and which controls with medical disorders of known organic pathology. So it is very important to evaluate the medical causes where anxiety is accompanied by the disproportionate physical symptoms as like Tachycardia or atypical physical symptom like confusion. The main psychosomatic therapy which is knows as Cognitive behavioral therapy (CBT) should be concerned as a first-line treatment for the situational anxiety and also the anxiety disorders. The use of Benzodiazepines which can help to improve primary anxiety in a short term and Tricyclic Antidepressants like Mirtazapine were also considered. Selective serotonin reuptake inhibitors, selective norepinephrine reuptake inhibitors were also used in the psychosomatic therapies.

  • Melancholia
  • Mindfulness , Philosophy and Mindful Practices
  • Geriatric Depression
  • Stress and Insomnia
  • Anxiety Management
  • Stress Management and Therapies
  • Suicide and Selfharm
  • Yoga and Meditation
  • Suicide and its Prevention
  • Specific Phobias and Treatment
  • Spirituality and Buddhism
  • Anxiety Disorders

Related Conference of Stress, Depression and Anxiety Disorders

March 18-19, 2024

34th Euro Congress on Psychiatrists and Psychologists

Zurich, Switzerland
April 11-12, 2024

4th Annual Congress on Mental Health

Amsterdam, Netherlands
May 23-24, 2024

41th Global Psychiatry and Mental Health Conference

Zurich, Switzerland
May 27-28, 2024

6th European Autism Congress

Paris, France
July 15-16, 2024

6th International Congress on Mental Health

Amsterdam, Netherlands
September 09-10, 2024

5th Annual Congress on Psychiatry

London, UK

Stress, Depression and Anxiety Disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in